{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1047.376",
  "meta": {
    "versionId": "17",
    "lastUpdated": "2016-12-27T01:00:03.000-05:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.376",
  "version": "20161227",
  "name": "Moderate Emetic Risk Cancer MEdicine interferon alfa 2b",
  "status": "active",
  "date": "2016-12-27T01:00:03-05:00",
  "publisher": "Oncology Nursing Society Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "concept": [
          {
            "code": "5880",
            "display": "Interferon Alfa-2b"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:a9aa6904-89e2-450b-9d70-c3a59e661d02",
    "timestamp": "2022-06-10T09:50:24-04:00",
    "total": 1,
    "offset": 0,
    "parameter": [
      {
        "name": "count",
        "valueInteger": 1000
      },
      {
        "name": "offset",
        "valueInteger": 0
      }
    ],
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "code": "5880",
        "display": "interferon alfa-2b"
      }
    ]
  }
}